Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib with Chemo-Radiotherapy for Glioblastoma
NCT00869401Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2009
- Primary completion
- Oct 2014
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dasatinib in glioblastoma multiforme (GBM), sponsored by Cancer and Leukemia Group B. Started Jun 2009; status: completed.
02
Drugs
dasatinib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00869401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869401.